Metraipolis › archive › dc_9925e91c93d3

Clinical Benefits of Combination Immunotherapy Over Standard Immunotherapy Monotherapy in Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A… — Europe PMC PMID:41163421

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41163421
DOI
10.1002/cam4.71329
License (as archived)
solo-consultazione
Archived
2026-11-08T20:52:37.245Z
SHA-256 of the archived text
914ff1519fed9491e31003f80cb1b1a61a2a0ad9c1c897ab790d1d1d47c0f8db
Stable URL of this page
https://metraipolis.com/documento/dc_9925e91c93d3

How to cite

Clinical Benefits of Combination Immunotherapy Over Standard Immunotherapy Monotherapy in Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A… — Europe PMC PMID:41163421 — Europe PMC (en), https://europepmc.org/article/MED/41163421 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9925e91c93d3 (Metraipolis archive dc_9925e91c93d3, sha256 914ff1519fed9491e31003f80cb1b1a61a2a0ad9c1c897ab790d1d1d47c0f8db)
BibTeX
@misc{dc9925e91c93d3,
  title = {Clinical Benefits of Combination Immunotherapy Over Standard Immunotherapy Monotherapy in Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A… — Europe PMC PMID:41163421},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41163421},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9925e91c93d3; sha256 914ff1519fed9491e31003f80cb1b1a61a2a0ad9c1c897ab790d1d1d47c0f8db},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41163421. Agents can read the archived copy with the MCP tool read_document.